Content area
Full text
Boehringer Ingelheim is looking to spark some excitement across the antacids aisle with the June launch of its Duo Fusion combination antacid, "from the makers of Zantac," which couples a fast-acting heartburn remedy with an H2 blocker to provide both immediate and longer-lasting relief from heartburn. "We saw an opportunity to trade up consumers from antacids to an H2 [blocker]," said Marc Rovner, general manager Boehringer Ingelheim Consumer Healthcare, in an interview with Drug Store News. "[It's] an opportunity to address the needs of consumers who weren't being satisfied [with] a product that gave them the instant relief associated with an antacid, but at the same time lasts longer than an antacid."